Interventional Cardiology Journal Open Access

  • ISSN: 2471-8157
  • Journal h-index: 5
  • Journal CiteScore: 0.33
  • Journal Impact Factor: 0.26
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +32 25889658

The use of the Intravenous Laser Blood Irradiation (ILBI) of 630-640 nm for the prevention of the appearance of vascular diseases and the increase of life expectancy

EuroSciCon Conference on Clinical Cardiology and Cardiovascular Disease
May 24-25, 2018 London, UK

Vladimir A. Mikhaylov

Eternity Medicine Institute, UAE

Scientific Tracks Abstracts: Interv Cardiol J

Abstract:

The mortality from the diseases due to the affection of vessels came out now on the first place. The use of the Intravenous Laser Blood Irradiation (ILBI) within the last 30 years showed its high efficiency in a treatment of diseases of vessels and heart, and other system diseases. Therefore, ILBI as the method of the system impact on the blood system allows to lower the lethality and to increase the life expectancy. The lasers used for treatment of various diseases of which the waves having length of 630-640 nm are the most effective for the direct impact on the blood and the vascular wall. The energy of the waves of this length is absorbed by oxygen, improves the microcirculation in tissues, changes the viscosity of the blood and affects the wall of vessels

Biography :

Vladimir A. Mikhaylov has completed his PhD in the 1988 in National center  in laser medicine, Moscow. 1994 - received a degree Sci.D. in Natioal center on laser medicine, Moscow. 2009 - Has been recognized as an International Medical Laser Specialist at class: Hon-IMeLa, Tokio, Since 2000 - a member of editorial board of the “Laser Therapy. In 2016 - Prof. Ming-Chien Kao Award, Laser Therapy. He has published more than 25 papers in reputed journals.
Email:mlasass@mail.ru